Anne Louise Askou

In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells

Andreas Holmgaard, Anne Louise Askou, Josephine Natalia Esther Benckendorff et al. · Molecular Therapy — Nucleic Acids · 2017 · 73 citations · Full text

Reduced Expression of Cytoskeletal and Extracellular Matrix Genes in Human Adult Retinal Pigment Epithelium Cells Exposed to Simulated Microgravity

Thomas J. Corydon, Vivek Mann, Lasse Slumstrup et al. · Cellular Physiology and Biochemistry · 2016 · 66 citations · Full text

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy

Anne Louise Askou, Sidsel Alsing, Josephine Natalia Esther Benckendorff et al. · Molecular Therapy — Nucleic Acids · 2019 · 64 citations · Full text

Reduction of choroidal neovascularization in mice by adeno‐associated virus‐delivered anti‐vascular endothelial growth factor short hairpin RNA

Anne Louise Askou, Jean‐Antoine Pournaras, Maria Pihlmann Kristensen et al. · The Journal of Gene Medicine · 2012 · 54 citations

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and <i>in vivo</i> gene modification

Jakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial et al. · Nucleic Acids Research · 2023 · 52 citations · Full text

Engineering, In Vivo Gene Therapy, Molecular Biology +20